These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 19258214

  • 1. Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART).
    Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG.
    Eur J Med Res; 2009; 14(2):59-64. PubMed ID: 19258214
    [Abstract] [Full Text] [Related]

  • 2. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
    Teichmann J, Stephan E, Lange U, Discher T, Friese G, Lohmeyer J, Stracke H, Bretzel RG.
    J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
    [Abstract] [Full Text] [Related]

  • 3. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK.
    J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
    [Abstract] [Full Text] [Related]

  • 4. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone and bone mineral densitiy in HIV-1-infected male subjects.
    Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG.
    Eur J Med Res; 2008 Apr 30; 13(4):173-8. PubMed ID: 18504173
    [Abstract] [Full Text] [Related]

  • 6. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A.
    J Clin Endocrinol Metab; 1996 Dec 30; 81(12):4358-65. PubMed ID: 8954042
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children.
    Mora S, Zamproni I, Beccio S, Bianchi R, Giacomet V, Viganò A.
    J Clin Endocrinol Metab; 2004 Jan 30; 89(1):24-8. PubMed ID: 14715822
    [Abstract] [Full Text] [Related]

  • 9. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP, Yu XB, Luo L, Han Y, Qiu ZF, Zuo LY, Li YL, Yu W, Li TS.
    Zhonghua Nei Ke Za Zhi; 2010 Aug 30; 49(8):649-52. PubMed ID: 20979781
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy.
    Mora S, Sala N, Bricalli D, Zuin G, Chiumello G, Viganò A.
    AIDS; 2001 Sep 28; 15(14):1823-9. PubMed ID: 11579244
    [Abstract] [Full Text] [Related]

  • 11. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
    Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J.
    Calcif Tissue Int; 1997 Feb 28; 60(2):148-54. PubMed ID: 9056162
    [Abstract] [Full Text] [Related]

  • 12. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB, Xie J, Han Y, Qiu ZF, Li YL, Song XJ, Yu W, Li TS.
    Zhonghua Yi Xue Za Zhi; 2012 May 08; 92(17):1155-8. PubMed ID: 22883000
    [Abstract] [Full Text] [Related]

  • 13. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
    Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA.
    HIV Clin Trials; 2003 May 08; 4(5):337-46. PubMed ID: 14583850
    [Abstract] [Full Text] [Related]

  • 14. Hypovitaminosis D and bone mineral density in human immunodeficiency virus-infected men from India, with or without antiretroviral therapy.
    Paul TV, Asha HS, Thomas N, Seshadri MS, Rupali P, Abraham OC, Pulimood SA, Jose A.
    Endocr Pract; 2010 May 08; 16(4):547-53. PubMed ID: 20150027
    [Abstract] [Full Text] [Related]

  • 15. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG.
    J Endocrinol Invest; 2000 May 08; 23(5):295-303. PubMed ID: 10882147
    [Abstract] [Full Text] [Related]

  • 16. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G, Spanu A, Solinas P, Babudieri S, Calia GM, Lovigu C, Mannazzu M, Nuvoli S, Piras B, Bagella P, Mura MS, Madeddu G.
    Eur Rev Med Pharmacol Sci; 2015 Dec 08; 19(23):4576-89. PubMed ID: 26698255
    [Abstract] [Full Text] [Related]

  • 17. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.
    Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J.
    AIDS; 2003 Sep 05; 17(13):1917-23. PubMed ID: 12960824
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.